Search hospitals > Utah > Farmington
Farmington Health Center
Claim this profileFarmington, Utah 84025
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Adenocarcinoma
Conducts research for Tumors
Conducts research for Pancreatic Cancer
71 reported clinical trials
20 medical researchers
Summary
Farmington Health Center is a medical facility located in Farmington, Utah. This center is recognized for care of Cancer, Breast Cancer, Adenocarcinoma, Tumors, Pancreatic Cancer and other specialties. Farmington Health Center is involved with conducting 71 clinical trials across 227 conditions. There are 20 research doctors associated with this hospital, such as Heloisa Soares, Theresa Werner, MD, Joe Mendez, MD, and Howard Colman, MD, PhD.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderHER2 negative
HER2 positive
ER positive
Top PIs
Heloisa SoaresHuntsman Cancer Institute/University of Utah2 years of reported clinical research
Expert in Neuroendocrine Tumors
Studies Colorectal Cancer
25 reported clinical trials
50 drugs studied
Theresa Werner, MDHuntsman Cancer Institute/University of Utah2 years of reported clinical research
Studies Ovarian Cancer
Studies Adenocarcinoma
11 reported clinical trials
20 drugs studied
Joe Mendez, MDHuntsman Cancer Institute/University of Utah5 years of reported clinical research
Studies Glioblastoma
Studies Brain Tumor
11 reported clinical trials
20 drugs studied
Howard Colman, MD, PhDHuntsman Cancer Institute/University of Utah5 years of reported clinical research
Studies Glioblastoma
Studies Brain Tumor
12 reported clinical trials
31 drugs studied
Clinical Trials running at Farmington Health Center
Breast Cancer
Gastric Cancer
Esophageal Cancer
Esophageal Adenocarcinoma
Adenocarcinoma
Small Cell Lung Cancer
Prostate Cancer
Pancreatic Cancer
Cancer
Gastroesophageal Junction Adenocarcinoma
Radiation and HER2-Targeted Therapy
for Breast Cancer
This Phase III trial compares the recurrence-free interval (RFI) among patients with early-stage, low risk HER2+ breast cancer who undergo breast conserving surgery and receive HER2-directed therapy, and are randomized to not receive adjuvant breast radiotherapy versus those who are randomized to receive adjuvant radiotherapy per the standard of care.
Recruiting2 awards Phase 315 criteria
Omitting Radiation Therapy
for Breast Cancer
The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers want to see if not giving this type of radiation treatment works as well at preventing breast cancer from coming back.
Recruiting2 awards Phase 319 criteria
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Farmington Health Center?
Farmington Health Center is a medical facility located in Farmington, Utah. This center is recognized for care of Cancer, Breast Cancer, Adenocarcinoma, Tumors, Pancreatic Cancer and other specialties. Farmington Health Center is involved with conducting 71 clinical trials across 227 conditions. There are 20 research doctors associated with this hospital, such as Heloisa Soares, Theresa Werner, MD, Joe Mendez, MD, and Howard Colman, MD, PhD.